Rise in prevalence of cancer, genetic disorders, and viral infections; and increase in awareness about vaccination drive the global mRNA vaccines market Outbreak of COVID-19 and rise in number of prominent market players conducting clinical trials for vaccine development are projected to drive the global market during the forecast period. There has been significant increase in the licensing agreement between manufacturers for the development of mRNA vaccine and therapeutics. Moreover, increase in approval of from various regulatory bodies such as FDA, CE and others are also expected to drive the growth of mRNA vaccines and therapeutic market. The increase in research and development activities coupled with advanced technology is expected to create ample opportunities on a long run. However, high cost involved in the development of mRNA vaccine and therapeutic market is expected to hinder the growth of mRNA vaccines and therapeutics market in the near future

1 INTRODUCTION

2 EXECUTIVE SUMMARY 

3 MARKET OUTLOOK

4 MRNA VACCINES & THERAPEUTICS TYPE ANALYSIS 

5 MRNA VACCINES & THERAPEUTICS MARKET VACCINE TYPE ANALYSIS

6 MRNA VACCINES & THERAPEUTICS MARKET TREATMENT TYPE ANALYSIS 

7 MRNA VACCINES & THERAPEUTICS MARKET VACCINE MANUFACTURING ANALYSIS

8 MRNA VACCINES & THERAPEUTICS MARKET END USER ANALYSIS 

9 MRNA VACCINES & THERAPEUTICS MARKET APPLICATION ANALYSIS 

10 GLOBAL MRNA VACCINES & THERAPEUTICS REGIONAL ANALYSIS

11 MARKET PLAYERS